Neuromuscular DiseasesNeuromuscular DiseasesНервно-мышечные болезни2222-87212413-0443Publishing House ABV Press16810.17650/2222-8721-2016-6-3-24-27LECTURES AND REVIEWSЛЕКЦИИ И ОБЗОРЫ.Распространенность болезни Помпе у пациентов с идиопатической гиперкреатинкиназемией и слабостью поясно-конечностных мышц (анализ 3076 случаев)*ZoltanLukacs
Germany
Nieves CobosPaulina
Germany
WenningerStephan
Germany
WillisTracey A.
United Kingdom
GuglieriMichela
United Kingdom
RobertsMarc
United Kingdom
QuinlivanRosaline
United Kingdom
Hilton-JonesDavid
United Kingdom
EvangelistaTeresinha
United Kingdom
ZierzStephan
Germany
Schlotter-WeigelBeate
Germany
WalterMaggie C
Germany
ReilichPeter
Germany
KlopstockThomas
Germany
DeschauerMarcus
Germany
StraubVolker
United Kingdom
Müller-FelberWolfgang
Germany
SchoserBenedikt
Germany
bschoser@med.uni-muenchen.deNewborn Screening and Metabolic Diagnostics Unit, Hamburg University Medical CenterHamburg, GermanyDepartment of Neurology, Friedrich-Baur-Institut, Medizinische Klinik, University of MunichMunich, GermanyThe Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation TrustOswestry, United KingdomInstitute of Genetic MedicineNewcastle, United KingdomSalford Royal NHS Foundation TrustSalford, United KingdomUCL Institute of Neurology and National Hospital, Queen SquareLondon, United KingdomDepartment of Neurology, Oxford University HospitalOxford, United KingdomDepartment of Neurology, Halle UniversityHalle, GermanyDepartment of Neurology, Friedrich-Baur-Institut, Medizinische Klinik,University of MunichMunich, GermanyInstitute of Genetic MedicineNewcastle, United KingdomDepartment of Neuropediatrics, Dr. Von Haunersche Kinderklinik Ludwig Maximilian University of Munich160420196324271210201612102016Copyright ©; 2019, Zoltan L., Nieves Cobos P., Wenninger S., Willis T.A., Guglieri M., Roberts M., Quinlivan R., Hilton-Jones D., Evangelista T., Zierz S., Schlotter-Weigel B., Walter M.C., Reilich P., Klopstock T., Deschauer M., Straub V., Müller-Felber W., Schoser B.Copyright ©; 2019, Zoltan L., Nieves Cobos P., Wenninger S., Willis T.A., Guglieri M., Roberts M., Quinlivan R., Hilton-Jones D., Evangelista T., Zierz S., Schlotter-Weigel B., Walter M.C., Reilich P., Klopstock T., Deschauer M., Straub V., Müller-Felber W., Schoser B.2019Zoltan L., Nieves Cobos P., Wenninger S., Willis T.A., Guglieri M., Roberts M., Quinlivan R., Hilton-Jones D., Evangelista T., Zierz S., Schlotter-Weigel B., Walter M.C., Reilich P., Klopstock T., Deschauer M., Straub V., Müller-Felber W., Schoser B.Zoltan L., Nieves Cobos P., Wenninger S., Willis T.A., Guglieri M., Roberts M., Quinlivan R., Hilton-Jones D., Evangelista T., Zierz S., Schlotter-Weigel B., Walter M.C., Reilich P., Klopstock T., Deschauer M., Straub V., Müller-Felber W., Schoser B.https://creativecommons.org/licenses/by/4.0https://nmb.abvpress.ru/jour/article/view/168

.

1. van der Ploeg A.T., Reuser A.J. Pompe’s disease. Lancet 2008;372(9646):1342–53. DOI: 10.1016/S0140-6736(08)61555-X. PMID: 18929906.van der Ploeg A.T., Reuser A.J. Pompe’s disease. Lancet 2008;372(9646):1342–53. DOI: 10.1016/S0140-6736(08)61555-X. PMID: 18929906.2. Gьngцr D., de Vries J.M., Hop W.C. et al. Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy. Orphanet J Rare Dis 2011;6:34. DOI: 10.1186/1750-1172-6-34. PMID: 21631931.Gьngцr D., de Vries J.M., Hop W.C. et al. Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy. Orphanet J Rare Dis 2011;6:34. DOI: 10.1186/1750-1172-6-34. PMID: 21631931.3. Schьller A., Wenninger S., Strigl-Pill N., Schoser B. Toward deconstructing the phenotype of late-onset Pompe disease. Am J Med Genet C Semin Med Genet 2012;160C(1):80–8. DOI: 10.1002/ajmg.c.31322. PMID: 22253010.Schьller A., Wenninger S., Strigl-Pill N., Schoser B. Toward deconstructing the phenotype of late-onset Pompe disease. Am J Med Genet C Semin Med Genet 2012;160C(1):80–8. DOI: 10.1002/ajmg.c.31322. PMID: 22253010.4. Kishnani P.S., Amartino H.M., Lindberg C. et al. Timing of diagnosis of patients with Pompe disease: data from the Pompe registry.Am J Med Genet A 2013;161A(10):2431–43. DOI: 10.1002/ajmg.a.36110. PMID: 23997011.Kishnani P.S., Amartino H.M., Lindberg C. et al. Timing of diagnosis of patients with Pompe disease: data from the Pompe registry.Am J Med Genet A 2013;161A(10):2431–43. DOI: 10.1002/ajmg.a.36110. PMID: 23997011.5. Lukacs Z., Nieves C.P., Mengel E. et al. Diagnostic efficacy of the fluorometric determination of enzyme activity for Pompe disease from dried blood specimens compared with lymphocytes: possibility for newborn screening. J Inherit Metab Dis 2010;33(1):43–50. DOI: 10.1007/s10545- 009-9003-z. PMID: 20033296.Lukacs Z., Nieves C.P., Mengel E. et al. Diagnostic efficacy of the fluorometric determination of enzyme activity for Pompe disease from dried blood specimens compared with lymphocytes: possibility for newborn screening. J Inherit Metab Dis 2010;33(1):43–50. DOI: 10.1007/s10545- 009-9003-z. PMID: 20033296.6. Gutiйrrez-Rivas E., Bautista J., Vнlchez J.J. et al. Targeted screening for the detection of Pompe disease in patients with unclassified limb-girdle muscular dystrophy or asymptomatic hyperCKemia using dried blood: a Spanish cohort. Neuromuscul Disord 2015;25(7):548–53. DOI: 10.1016/j. nmd.2015.04.008. PMID: 25998610.Gutiйrrez-Rivas E., Bautista J., Vнlchez J.J. et al. Targeted screening for the detection of Pompe disease in patients with unclassified limb-girdle muscular dystrophy or asymptomatic hyperCKemia using dried blood: a Spanish cohort. Neuromuscul Disord 2015;25(7):548–53. DOI: 10.1016/j. nmd.2015.04.008. PMID: 25998610.7. Musumeci O., la Marca G., Spada M. et al. LOPED Study: looking for an early diagnosis in a late-onset Pompe disease highrisk population. J Neurol Neurosurg Psychiatry 2016;87(1):5–11. DOI: 10.1136/jnnp-2014-310164. PMID: 25783438.Musumeci O., la Marca G., Spada M. et al. LOPED Study: looking for an early diagnosis in a late-onset Pompe disease highrisk population. J Neurol Neurosurg Psychiatry 2016;87(1):5–11. DOI: 10.1136/jnnp-2014-310164. PMID: 25783438.8. Palmio J., Auranen M., Kiuru-Enari S. et al. Screening for late-onset Pompe disease in Finland. Neuromuscul Disord 2014;24(11):982–5. DOI: 10.1016/j.nmd.2014.06.438. PMID: 25047669.Palmio J., Auranen M., Kiuru-Enari S. et al. Screening for late-onset Pompe disease in Finland. Neuromuscul Disord 2014;24(11):982–5. DOI: 10.1016/j.nmd.2014.06.438. PMID: 25047669.9. Spada M., Porta F., Vercelli L. et al. Screening for lateronset Pompe’s disease in patients with paucisymptomatic hyperCKemia. Mol Genet Metab 2013;109(2):171–3. DOI: 10.1016/j.ymgme.2013.03.002. PMID: 23566438.Spada M., Porta F., Vercelli L. et al. Screening for lateronset Pompe’s disease in patients with paucisymptomatic hyperCKemia. Mol Genet Metab 2013;109(2):171–3. DOI: 10.1016/j.ymgme.2013.03.002. PMID: 23566438.10. Preisler N., Lukacs Z., Vinge L. et al. Lateonset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies. Mol Genet Metab 2013;110(3):287–9. DOI: 10.1016/j. ymgme.2013.08.005. PMID: 24011652.Preisler N., Lukacs Z., Vinge L. et al. Lateonset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies. Mol Genet Metab 2013;110(3):287–9. DOI: 10.1016/j. ymgme.2013.08.005. PMID: 24011652.11. Goldstein J.L., Young S.P., Changela M. et al. Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory. Muscle Nerve 2009;40(1): 32–6. DOI: 10.1002/mus.21376. PMID: 19533645.Goldstein J.L., Young S.P., Changela M. et al. Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory. Muscle Nerve 2009;40(1): 32–6. DOI: 10.1002/mus.21376. PMID: 19533645.12. Pérez-López J., Selva-O’Callaghan A., Grau-Junyent J.M. et al. Delayed diagnosis of late-onset Pompe disease in patients with myopathies of unknown origin and/or hyper-CKemia. Mol Genet Metab 2015;114(4):580–3. DOI: 10.1016/j.ymgme.2015.02.004. PMID: 25752415.Pérez-López J., Selva-O’Callaghan A., Grau-Junyent J.M. et al. Delayed diagnosis of late-onset Pompe disease in patients with myopathies of unknown origin and/or hyper-CKemia. Mol Genet Metab 2015;114(4):580–3. DOI: 10.1016/j.ymgme.2015.02.004. PMID: 25752415.13. Никитин С.С. Бессимптомная гиперкреатинкиназемия в клинике нервно-мышечных болезней. Неврологический журнал 2015;20(5):26–33. DOI: 10.18821/1560-9545-2015-20-5-26-33. [Nikitin S.S. Asymptomatic elevation of creatine kinase in neuromuscular diseases. Nevrologicheskiy zhurnal = The Neurological Journal 2015;20(5):26–33. DOI: 10.18821/1560-9545-2015-20-5-26-33. (In Russ.)].Никитин С.С. Бессимптомная гиперкреатинкиназемия в клинике нервно-мышечных болезней. Неврологический журнал 2015;20(5):26–33. DOI: 10.18821/1560-9545-2015-20-5-26-33. [Nikitin S.S. Asymptomatic elevation of creatine kinase in neuromuscular diseases. Nevrologicheskiy zhurnal = The Neurological Journal 2015;20(5):26–33. DOI: 10.18821/1560-9545-2015-20-5-26-33. (In Russ.)].14. Schoser B., Toscano A. Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review. J Neurol 2013;260(4):951–9. DOI: 10.1007/s00415-012-6636-x. PMID: 22926164.Schoser B., Toscano A. Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review. J Neurol 2013;260(4):951–9. DOI: 10.1007/s00415-012-6636-x. PMID: 22926164.